Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Malin's Enterprise Value is $-35.25 Mil.
Malin's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.39 Mil. Therefore, Malin's EV-to-OCF for today is 25.36.
The historical rank and industry rank for Malin's EV-to-OCF or its related term are showing as below:
MLLNF'
s EV-to-OCF Range Over the Past 10 Years
Min: -127.9 Med: -62.3 Max: 22.15
Current: 22.15
During the past 10 years, the highest EV-to-OCF of Malin was 22.15. The lowest was -127.90. And the median was -62.30.
MLLNF's EV-to-OCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 10.55
vs MLLNF: 22.15
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-19), Malin's stock price is $6.40.
Malin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.044. Therefore, Malin's PE Ratio (TTM) for today is At Loss.
Malin (OTCPK:MLLNF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Malin's share price for today is $6.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Malin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.044.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Malin EV-to-OCF Related Terms
Malin EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Malin's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Malin's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Malin EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Malin's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Malin's EV-to-OCF falls into.
Malin's current Enterprise Value is $-35.25 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Malin's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malin (MLLNF) has a EV-to-OCF of 25.36 as of Jul. 19, 2026.
Is Malin's EV-to-OCF too high?
Malin's current EV-to-OCF is 25.36. The Drug Manufacturers industry median EV-to-OCF is 10.55. Malin's value of 25.36 is 140.4% above this industry median. Overall, Malin has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Malin's EV-to-OCF compare to ZTS and UTHR?
Malin's EV-to-OCF of 25.36 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-OCF is 10.55. Malin's value of 25.36 is 140.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Malin's current EV-to-OCF of 25.36 is 140.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Malin's current EV-to-OCF is 25.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malin stock overvalued right now?
Malin (MLLNF) has a current EV-to-OCF of 25.36. The current EV-to-OCF is 25.36 and 140.4% above the Drug Manufacturers industry median of 10.55. Malin's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Malin (MLLNF), the current EV-to-OCF is 25.36 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Malin Corporation PLC is a life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in the life sciences industry. The company derives all of its revenue from its subsidiary. The company focuses on oncology, immunology, and genetic diseases where it believes that life science and healthcare technologies will deliver transformative treatments for patients.
17GF Score
Get the complete analysis for MLLNF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLLNF has been successfully added to your 
